Conventional Bronchoscope With BAL vs. Thin Bronchoscope With BW to Diagnose Pulmonary TB
Launched by PUSAN NATIONAL UNIVERSITY HOSPITAL · Nov 28, 2023
Trial Information
Current as of August 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two different methods for diagnosing pulmonary tuberculosis (TB), which is an infection that affects the lungs. The researchers want to see which method works better: one using a thick, traditional bronchoscope that collects fluid from the lungs (called bronchoalveolar lavage or BAL) or another using a thin bronchoscope that washes the airways (called bronchial washing or BW). The goal is to find out which technique can identify TB more effectively in patients who are suspected of having the disease.
To participate in this study, individuals need to be over 17 years old and have symptoms or signs of active pulmonary TB shown on a chest X-ray or CT scan. They should have negative test results for TB from sputum samples, meaning they couldn’t produce enough mucus to test. However, people who are already being treated for TB or have certain medical conditions that make bronchoscopy risky will not be included. Participants will undergo one of the two diagnostic procedures, and the study is currently looking for volunteers to help improve TB diagnosis methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • participants age \> 17 years with suspected pulmonary TB
- • possible active pulmonary TB evident on chest radiography or CT scan
- • negative AFB smear results (using two consecutive self-expectorated sputum)
- • negative TB-PCR results (using one self-expectorated sputum)
- • inability to produce self-expectorated sputum
- Exclusion Criteria:
- • a request for empirical TB treatment rather than bronchoscopy
- • suspect pulmonary TB lesions that are difficult to target for BAL or BW (e.g., multiple discrete tiny nodules)
- • contra-indication of bronchoscopy (e.g., bleeding tendency, hypoxemia requiring oxygen, or uncontrolled cardio/cerebrovascular disease)
About Pusan National University Hospital
Pusan National University Hospital is a leading academic medical institution located in Busan, South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge technology and multidisciplinary expertise to facilitate the development of new therapies and improve patient outcomes. With a strong emphasis on ethical standards and patient safety, Pusan National University Hospital collaborates with a diverse array of researchers and healthcare professionals to contribute to the global medical community and enhance evidence-based practices in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Busan, , Korea, Republic Of
Patients applied
Trial Officials
Jeongha Mok
Principal Investigator
Pusan National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported